|
|
||||||||
Technical Briefs |
1
Departments of Internal Medicine and
2
Laboratory Medicine and
3
Graduate Institute of Medical Technology, College of Medicine, National Taiwan University, Taiwan, Republic of China; Fax 886-2-23411876
a address for correspondence: Department of Laboratory Medicine, College of Medicine, National Taiwan University, 7, Chun-Sun South Rd., Taipei 10016, Taiwan, Republic of China
The angiotensin-converting enzyme (ACE) gene product plays an important role in cardiovascular homeostasis. An insertion/deletion (I/D) polymorphism in intron 16 of the ACE gene, with insertion polymorphism containing three more Alu-repeat sequences, was reported to be a determining factor of the plasma ACE concentration, and the D polymorphism has been found to be associated with certain cardiovascular diseases (1)(2)(3)(4)(5). Controversy exists, however, regarding the strength of the association. The diversity of conclusions has been attributed to methodological and technical variations in detection of the polymorphisms (6)(7). The preferential amplification of the D allele of the ACE gene by the PCR reported by Rigat et al. (8) was thought to be one cause. This PCR method occasionally mistyped ID heterozygotes as DD homozygotes (9). The probability of this mistyping has been estimated to be ~510% (6)(7). A confirmatory PCR method, which requires an additional third PCR primer inside the Alu sequence of the I allele, was proposed to minimize the mistyping of the I allele as a D allele (9). Although this PCR technique was reported to be 100% in the typing of ACE gene polymorphisms, problems with the preferential amplification of multiplexed PCR are not entirely excluded with this method (10)(11).
A stepdown PCR method, modified from touchdown PCR, has recently been
used in several molecular studies (12). This method involves
initial PCR annealing temperatures higher than the melting point of the
primers, followed by annealing temperatures reduced stepwise to the
melting point. This method should result in higher amplification
specificity and greater yield. We compared the stepdown PCR with the
conventional method from Rigat et al. (8)
Acknowledgments
References
The following articles in journals at HighWire Press have cited this article:
![]() |
S. Cunat, M. Giansily-Blaizot, M. Bismuth, F. Blanc, O. Dereure, D. Larrey, A. L. Quellec, P. Pouderoux, C. Rose, I. Raingeard, et al. Global Sequencing Approach for Characterizing the Molecular Background of Hereditary Iron Disorders Clin. Chem., December 1, 2007; 53(12): 2060 - 2069. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-T. Tsai, L.-P. Lai, J.-L. Lin, F.-T. Chiang, J.-J. Hwang, M. D. Ritchie, J. H. Moore, K.-L. Hsu, C.-D. Tseng, C.-S. Liau, et al. Renin-Angiotensin System Gene Polymorphisms and Atrial Fibrillation Circulation, April 6, 2004; 109(13): 1640 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-T. Tsai, D. Fallin, F.-T. Chiang, J.-J. Hwang, L.-P. Lai, K.-L. Hsu, C.-D. Tseng, C.-S. Liau, and Y.-Z. Tseng Angiotensinogen Gene Haplotype and Hypertension: Interaction With ACE Gene I Allele Hypertension, January 1, 2003; 41(1): 9 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Somogyvari, Z. Szolnoki, J. Marki-Zay, and L. Fodor Real-Time PCR Assay with Fluorescent Hybridization Probes for Exact and Rapid Genotyping of the Angiotensin-converting Enzyme Gene Insertion/Deletion Polymorphism Clin. Chem., September 1, 2001; 47(9): 1728 - 1729. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |